INCE vs SBIO
Franklin Income Equity Focus ETF vs ALPS Medical Breakthroughs ETF
Quick Verdict
INCE has a lower expense ratio. SBIO delivered stronger 1-year returns. SBIO offers more diversification with 105 holdings.
Side-by-Side Comparison
| Metric | INCE | SBIO | Winner |
|---|---|---|---|
| Expense Ratio | 0.29% | 0.50% | |
| AUM | $132M | $202M | |
| Dividend Yield | 4.82% | 4.05% | |
| Holdings | 82 | 87 | |
| YTD Return | +17.14% | +35.11% | |
| 1Y Return | +26.04% | +101.30% | |
| 3Y Return (annualized) | +16.96% | +32.81% | |
| 5Y Return (annualized) | +10.99% | +9.88% | |
| Volatility (annualized) | 13.8% | 29.6% | |
| Max Drawdown | -34.1% | -63.1% | |
| Fund Family | Franklin Templeton Investments (US) | ALPS Advisors | |
| Category | Equity | Equity | |
| Inception | Sep 20, 2016 | Dec 30, 2014 |
INCE vs SBIO Performance
Franklin Income Equity Focus ETF (INCE) is a ETF from Franklin Templeton Investments (US) and ALPS Medical Breakthroughs ETF (SBIO) is a ETF from ALPS Advisors. Over the past year INCE returned +26.04% while SBIO returned +101.30%. Year to date, INCE is up 17.14% versus a gain of 35.11% for SBIO.
Over three years, INCE compounded at +16.96% per year against +32.81% for SBIO; over five years the annualized figures are +10.99% and +9.88% respectively. Across the full 10-year window we track, INCE has the edge at +12.63% annualized vs +9.81%. Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
SBIO has been the more volatile fund, with annualized monthly volatility of 29.6% compared with 13.8% for INCE. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -34.1% for INCE and -63.1% for SBIO. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
The two funds' monthly returns correlate at 0.50. They move independently enough that combining them can meaningfully diversify a portfolio.
Fees and Cost Over Time
INCE charges 0.29% per year while SBIO charges 0.50%. On a $10,000 position that is $29 vs $50 annually, a gap of $21 per year that compounds over a long holding period. On income, INCE currently yields 4.82% against 4.05% for SBIO.
Holdings Overlap
INCE and SBIO share 1 holdings out of 151 unique holdings combined, representing a 0.0% weight overlap.
Moderate overlap means holding both could provide meaningful diversification benefits.
Top Shared Holdings
| Stock | Weight in INCE | Weight in SBIO | Difference |
|---|---|---|---|
| AZN:LN | 0.71% | 0.00% | 0.71% |
Frequently Asked Questions
Which is cheaper, INCE or SBIO?
INCE has an expense ratio of 0.29% while SBIO charges 0.50%. INCE is the cheaper option. On a $10,000 investment, that is $21 per year of difference.
Which performed better, INCE or SBIO?
Over the past year INCE returned +26.04% vs +101.30% for SBIO, so SBIO leads on 1-year performance. Over the longest common window we track (10 years), INCE annualized +12.63% vs +9.81% for SBIO. Past performance does not guarantee future results.
Which is riskier, INCE or SBIO?
SBIO has been the more volatile fund at 29.6% annualized versus 13.8% for INCE. Worst drawdown: INCE -34.1% vs SBIO -63.1%.
Should I hold both INCE and SBIO?
INCE and SBIO have a monthly-return correlation of 0.50, so combining them can provide real diversification depending on your allocation goals.
What is the holdings overlap between INCE and SBIO?
INCE and SBIO share 1 common holdings with a 0.0% weight overlap. Combined, they hold 151 unique securities.
Which pays a higher dividend, INCE or SBIO?
INCE yields 4.82% while SBIO yields 4.05%, so INCE currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.